Special shareholders' meeting approves all motions

Waregem  (Belgium)  /  Rotterdam  (The  Netherlands)  [1], 27 January 2010 - The
special  shareholders' meeting held by Arseus  NV today approved all motions put
forward  by the  Board of  Directors. The  minutes of  the special shareholders'
meeting  are  available  on  the  Arseus  corporate  website  at  www.Arseus.com
<http://www.arseus.com/>.
 
For more information please contact:
 
Constantijn van Rietschoten
 
Investor Relations Manager
 
+31 88 33 11 222 (office)
 
+31 6 536 91 585 (mobile)
 
constantijn.van.rietschoten@arseus.com
 
Profile Arseus
 
Arseus  is a multinational  group of companies  that supplies products, services
and  concepts  to  professionals  and  institutions  in  the European healthcare
sector. Arseus is subdivided into four divisions and operates in the markets for
pharmaceutical compounding for pharmacies, dental products, medical and surgical
products,   and  medical  IT-solutions.  In  2009 Arseus  realised  turnover  of
approximately  ¤391 million  with 1,600 employees  in 16 European countries. The
Belgian  company Arseus  NV is  located in  Waregem, and  is listed  on Euronext
Brussels  and Euronext Amsterdam. The operational activities of the Arseus group
are  driven by  the Dutch  company Arseus  BV. The  head office  of Arseus BV is
located in Rotterdam.
 
In the event of any discrepancy between the English translation and the original
Dutch version of this press release, the latter shall prevail.
 
[1] This press release was sent out by Arseus NV and Arseus BV.
 
[HUG#1377949]
 
Special shareholders meeting approves all motions: http://hugin.info/138311/R/1377949/338641.pdf